ASP Isotopes Inc. (ASPI) Guidance & Earnings Results
On 2026-08-04 ASP Isotopes Inc. raised guidance: "PET Labs FY2026 revenue guidance raised to ~$14M from $6M in FY2025; helium revenue guidance ~$27M annualized; 2031 EBITDA target >$300M…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ASPIASP Isotopes Inc.Follow ASPI — free
—
Price chart with a free account
- Market cap
- 298.2M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 17 Nov, in 24 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 4 Aug 26 | Raised | PET Labs FY2026 revenue guidance raised to ~$14M from $6M in FY2025; helium revenue guidance ~$27M annualized; 2031 EBITDA target >$300M reaffirmed |
ASP Isotopes Inc. — questions
- What guidance did ASP Isotopes Inc. give?
- On 2026-08-04: "PET Labs FY2026 revenue guidance raised to ~$14M from $6M in FY2025; helium revenue guidance ~$27M annualized; 2031 EBITDA target >$300M reaffirmed"
- When does ASP Isotopes Inc. report earnings?
- ASP Isotopes Inc.'s next earnings report is expected on 2026-11-17.
Every figure on this page comes from ASP Isotopes Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.